PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 1,904 Shares of Stock

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 1,904 shares of the stock in a transaction on Thursday, October 29th. The stock was sold at an average price of $50.05, for a total value of $95,295.20. Following the completion of the sale, the chief executive officer directly owned 54,179,397 shares in the company, valued at approximately $2,711,678,819.85. This represents a 0.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Wednesday, October 28th, Jason Murray sold 6,899 shares of PACS Group stock. The shares were sold at an average price of $50.10, for a total value of $345,639.90.
• On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The stock was sold at an average price of $48.60, for a total value of $3,349,366.20.
• On Thursday, October 22nd, Jason Murray sold 13,696 shares of PACS Group stock. The stock was sold at an average price of $47.55, for a total value of $651,244.80.
• On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The stock was sold at an average price of $47.62, for a total transaction of $314,768.20.
• On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The stock was sold at an average price of $47.65, for a total transaction of $1,785,779.05.
• On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The shares were sold at an average price of $47.57, for a total transaction of $77,063.40.
• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total transaction of $402,875.82.
• On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The shares were sold at an average price of $47.27, for a total transaction of $5,201,354.45.
• On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The stock was sold at an average price of $45.00, for a total transaction of $10,440.00.
• On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The stock was sold at an average price of $42.48, for a total transaction of $30,458.16.

PACS Group Trading Down 3.9%

Shares of NYSE PACS opened at $47.76 on Friday. The firm’s 50 day moving average price is $44.21 and its 200-day moving average price is $39.79. The company has a market cap of $7.56 billion, a PE ratio of 27.77, a P/E/G ratio of 1.55 and a beta of -0.08. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $50.38. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91.

PACS Group (NYSE:PACS) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. The firm had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. On average, equities research analysts expect that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.

PACS Group News Roundup

Here are the key news stories impacting PACS Group this week:

• Neutral Sentiment: CEO Jason Murray, Director Mark Hancock, and Chief Accounting Officer Michelle Lewis collectively sold approximately 33,935 shares for about $1.70 million at prices near $50 per share. However, the transactions were executed under pre-arranged 10b5-1 plans, and the executives continue to hold substantial positions. The sales therefore appear more consistent with scheduled diversification or liquidity needs than a clear indication of weakening confidence. Mark Hancock insider-trading filing Jason Murray insider-trading filing Michelle Lewis insider-trading filing
• Negative Sentiment: A shareholder-focused law firm issued an alert encouraging PACS investors to contact the Shareholders Foundation regarding a potential lawsuit. The notice provides no confirmed allegations or details about the case in the supplied report, so the immediate financial impact is uncertain, but litigation-related headlines can create additional volatility and concern around the stock. PACS shareholder lawsuit alert

Institutional Trading of PACS Group

A number of large investors have recently made changes to their positions in PACS. Squarepoint Ops LLC raised its holdings in shares of PACS Group by 94.7% during the second quarter. Squarepoint Ops LLC now owns 59,523 shares of the company’s stock valued at $2,538,000 after purchasing an additional 28,945 shares during the last quarter. Cantor Fitzgerald Investment Advisors L.P. purchased a new stake in PACS Group in the third quarter worth approximately $1,920,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in PACS Group in the second quarter worth approximately $1,893,000. Engineers Gate Manager LP purchased a new stake in PACS Group in the second quarter worth approximately $1,132,000. Finally, Smith Group Asset Management LLC bought a new stake in PACS Group in the 1st quarter worth approximately $771,000.

Wall Street Analyst Weigh In

Several brokerages have commented on PACS. Truist Financial set a $62.00 target price on PACS Group in a research note on Wednesday, September 2nd. Royal Bank Of Canada boosted their price target on PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. upped their price target on PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a report on Friday, September 4th. Weiss Ratings raised PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Finally, Oppenheimer increased their price objective on PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a research report on Monday, August 10th. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, PACS Group presently has an average rating of “Moderate Buy” and a consensus target price of $58.80.

About PACS Group

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.